Amiodarone induced optic neuropathy
Aim: To determine the clinical features of amiodarone induced optic neuropathy, which may help distinguish it from non-arteritic anterior ischaemic optic neuropathy. Methods: Retrospective observational case series of patients diagnosed with amiodarone induced optic neuropathy at the neuro-ophthalmo...
Saved in:
Published in | British journal of ophthalmology Vol. 87; no. 4; pp. 420 - 422 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01.04.2003
BMJ BMJ Publishing Group LTD Copyright 2003 British Journal of Ophthalmology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aim: To determine the clinical features of amiodarone induced optic neuropathy, which may help distinguish it from non-arteritic anterior ischaemic optic neuropathy. Methods: Retrospective observational case series of patients diagnosed with amiodarone induced optic neuropathy at the neuro-ophthalmology service from March 1998 to February 2001. Amiodarone was discontinued after discussion with the patient's cardiologist. Visual acuity, colour vision, automated perimetry, and funduscopy were performed on initial and follow up examinations. Results: Three patients with amiodarone induced optic neuropathy presented with mildly decreased vision, visual field defects, and bilateral optic disc swelling. Upon discontinuing the medication, visual function and optic disc swelling slowly improved in all three patients. Conclusion: Amiodarone induced optic neuropathy can present with visual dysfunction, and is typically a bilateral process. Upon discontinuation of amiodarone, slow resolution of optic disc swelling occurs and visual function improves in some patients. |
---|---|
Bibliography: | href:bjophthalmol-87-420.pdf PMID:12642303 istex:F5DFB04452699ACB8DFEC5D4F1435FB39248AB48 Correspondence to: Peter J Savino, MD, Neuro-Ophthalmology Service, Wills Eye Hospital, 900 Walnut Street, Philadelphia, PA 19107, SA; pjsavino@aol.com ark:/67375/NVC-T4J04KT6-S local:0870420 Correspondence to: Peter J Savino, MD, Neuro-Ophthalmology Service, Wills Eye Hospital, 900 Walnut Street, Philadelphia, PA 19107, SA; pjsavino@aol.com |
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjo.87.4.420 |